Introduction

Autoimmunity

Volumn 41, Issue 8, 2008, Pages 556-562

  Marmont, Alberto M ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; PREDNISOLONE; THYMOCYTE ANTIBODY;

ADOPTIVE IMMUNOTHERAPY; ALLOGENIC BONE MARROW TRANSPLANTATION; AUTOIMMUNE DISEASE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CHIMERA; CLINICAL EFFECTIVENESS; DRUG MEGADOSE; EDITORIAL; ENCEPHALOMYELITIS; ENVIRONMENTAL FACTOR; EXPERIMENTAL TRANSPLANTATION; GENETIC PREDISPOSITION; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREGULATION; NONHUMAN; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT CONTRAINDICATION; TREATMENT RESPONSE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; METHODOLOGY;

AUTOIMMUNE DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS;

EID: 65449122717     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930802197057     Document Type: Editorial

References (114)

1. Burt R, Marmont A, editors. (2004) Stem cell therapy for autoimmune disease, Landes Bioscience, Georgetown, TX
2. Keating, A. (2006) Mesenchymal stromal cells. Curr Opin Hematol, 13:6, pp. 419-425.
3. Horwitz, E., Andreef, M. and Frassoni, F. (2007) Mesenchymal stromal cells. Biol Blood Marrow Transplant, 13, pp. 53-57.
4. Chamberlain, G., Fox, J., Ashton, B. and Middleton, J. (2007) Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells, 25:11, pp. 2739-2749.
5. Nauta, AJ and Fibbe, WE (2007) Immunomodulatory properties of mesenchymal stromal cells. Blood, 110:10, pp. 3499-3506.
6. Ringden, O., Uzunel, M. Rasmusson, I. et al. (2006) Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation, 81:10, pp. 1390-1397.
7. Le Blanc, K and Ringden, O. (2005) Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant, 11:5, pp. 321-334.
8. El-Badri, NS, Maheshwari, A. and Sanberg, PR (2004) Mesenchymal stem cells in autoimmune disease. Stem Cells Dev, 13:5, pp. 463-472.
9. Uccelli, A., Moretta, L. and Pistoia, V. (2006) Immunoregulatory function of mesenchymal stem cells. Eur J Immunol, 36:10, pp. 2566-2573.
10. Griffith, LM, Pavletic, SZ Tyndall, A. et al. (2006) Target populations in allogeneic hematopoietic cell transplantation for autoimmune diseases-a workshop accompanying: Cellular therapy for treatment of autoimmune diseases, basic science and clinical studies, including new developments in hematopoietic and mesenchymal stem cell therapy. Biol Blood Marrow Transplant, 12:6, pp. 688-690.
11. Horwitz, EM, Le Blanc, K Dominici, M. et al. (2005) Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy, 7:5, pp. 393-395.
12. Sun, LY, Zhang, HY Feng, XB et al. (2007) Abnormality of bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus. Lupus, 16:2, pp. 121-128.
13. Marmont, AM (2000) New horizons in the treatment of autoimmune diseases: Immunoablation and stem cell transplantation. Annu Rev Med, 51, pp. 115-134.
14. Marmont, AM (2004) Historical perspective and rationale of HSCT for autoimmune diseases. Stem cell therapy for autoimmune disease, pp. 223-233. Landes Bioscience, Georgetown, TX
15. Kapoor, S., Wilson, AG Sharrack, B. et al. (2007) Haemopoietic stem cell transplantation-an evolving treatment for severe autoimmune and inflammatory diseases in rheumatology, neurology and gastroenterology. Hematology, 12:3, pp. 179-191.
16. Denman, AM, Russell, AS and Denman, EJ (1969) Adoptive transfer of the diseases of New Zealand black mice to normal mouse strains. Clin Exp Immunol, 5:6, pp. 567-595.
17. Morton, JI and Siegel, BV (1974) Transplantation of autoimmune potential. I. Development of antinuclear antibodies in H-2 histocompatible recipients of bone marrow from New Zealand Black mice. Proc Natl Acad Sci USA, 71:6, pp. 2162-2165.
18. Liu, K. and Mohan, C. (2007) What do mouse models teach us about human systemic lupus erythematosus?. Systemic lupus erythematosus, pp. 163-170. Mosby-Elsevier, London
19. Ikehara, S. (2001) Treatment of autoimmune diseases by hematopoietic stem cell transplantation. Exp Hematol, 29:6, pp. 661-669.
20. Levite, M., Zinger, H., Mozes, E. and Reisner, Y. (1993) Systemic lupus erythematosus-related autoantibody production in mice is determined by bone marrow-derived cells. Bone Marrow Transplant, 12:3, pp. 179-183.
21. Reininger, L., Radaszkiewicz, T. Kosco, M. et al. (1992) Development of autoimmune disease in SCID mice populated with long-term "in vitro" proliferating (NZB × NZW)F1 pre-B cells. J Exp Med, 176:5, pp. 1343-1353.
22. Ende, N., Czarneski, J. and Raveche, E. (1995) Effect of human cord blood transfer on survival and disease activity in MRL-lpr/lpr mice. Clin Immunol Immunopathol, 75:2, pp. 190-195.
23. Smith-Berdan, S., Gille, D., Weissman, IL and Christensen, JL (2007) Reversal of autoimmune disease in lupus-prone New Zealand black/New Zealand white mice by nonmyeloablative transplantation of purified allogeneic hematopoietic stem cells. Blood, 110:4, pp. 1370-1378.
24. Ikehara, S. (2005) Intra-bone marrow-bone marrow transplantation: A new strategy for treatment of stem cell disorders. Ann N Y Acad Sci, 1051, pp. 626-634.
25. Castello, S., Podesta, M. Menditto, VG et al. (2004) Intra-bone marrow injection of bone marrow and cord blood cells: An alternative way of transplantation associated with a higher seeding efficiency. Exp Hematol, 32:8, pp. 782-787.
26. Li, C., He, Y. Feng, X. et al. (2007) An innovative approach to bone marrow collection and transplantation in a patient with beta-thalassemia major: Marrow collection using a perfusion method followed by intra-bone marrow injection of collected bone marrow cells. Int J Hematol, 85:1, pp. 73-77.
27. Ehrenstein, M., Horsfall, A. and Isenberg, D. (1996) Immunopathology of lupus. The clinical management of systemic lupus erythematosus, pp. 17-34. Lippincott-Raven, New York, PA
28. Namjou, B., Kelly, J. and Harley, J. (2007) The genetics of lupus. Systemic lupus erythematosus, pp. 74-86. Mosby-Elsevier, London
29. Ermann, J. and Fathman, CG (2001) Autoimmune diseases: Genes, bugs and failed regulation. Nat Immunol, 2:9, pp. 759-761.
30. Randolph, DA and Fathman, CG (2006) Cd4 + Cd25 + regulatory T cells and their therapeutic potential. Annu Rev Med, 57, pp. 381-402.
31. Fridkis-Hareli, M., Zuniga, J. and Yunis, E. (2006) Hemopoietic stem cells and autoimmunity: Impaired mechanism of thymic selection or genetic predisposition?. J Stem Cells, 1, pp. 67-86.
32. Goodnow, CC, Sprent, J., Fazekas de St Groth, B and Vinuesa, CG (2005) Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature, 435:7042, pp. 590-597.
33. Sykes, M. and Nikolic, B. (2005) Treatment of severe autoimmune disease by stem-cell transplantation. Nature, 435:7042, pp. 620-627.
34. Van Wijmeersch, B., Sprangers, B. Rutgeerts, O. et al. (2007) Allogeneic bone marrow transplantation in models of experimental autoimmune encephalomyelitis: Evidence for a graft-versus-autoimmunity effect. Biol Blood Marrow Transplant, 13:6, pp. 627-637.
35. van Bekkum, DW (2004) Stem cell transplantation for autoimmune disorders. Preclinical experiments. Best Pract Res Clin Haematol, 17:2, pp. 201-222.
36. Lampeter, EF, Homberg, M. Quabeck, K. et al. (1993) Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation. Lancet, 341:8855, pp. 1243-1244.
37. Berisso, GA, van Lint, MT, Bacigalupo, A. and Marmont, AM (1999) Adoptive autoimmune hyperthyroidism following allogeneic stem cell transplantation from an HLA-identical sibling with Graves' disease. Bone Marrow Transplant, 23:10, pp. 1091-1092.
38. Kishimoto, Y., Yamamoto, Y. Ito, T. et al. (1997) Transfer of autoimmune thyroiditis and resolution of palmoplantar pustular psoriasis following allogeneic bone marrow transplantation. Bone Marrow Transplant, 19:10, pp. 1041-1043.
39. Bargetzi, MJ, Schonenberger, A. Tichelli, A. et al. (1997) Celiac disease transmitted by allogeneic non-T cell-depleted bone marrow transplantation. Bone Marrow Transplant, 20:7, pp. 607-609.
40. Sherer, Y. and Shoenfeld, Y. (1998) Autoimmune diseases and autoimmunity post-bone marrow transplantation. Bone Marrow Transplant, 22:9, pp. 873-881.
41. Lambertenghi-Deliliers, GL, Annaloro, C. Della Volpe, A. et al. (1997) Multiple autoimmune events after autologous bone marrow transplantation. Bone Marrow Transplant, 19:7, pp. 745-747.
42. Loh, Y., Oyama, Y. Statkute, L. et al. (2007) Development of a secondary autoimmune disorder after hematopoietic stem cell transplantation for autoimmune diseases: Role of conditioning regimen used. Blood, 109, pp. 2643-2648.
43. Sturfelt, G., Lenhoff, S. Sallerfors, B. et al. (1996) Transplantation with allogenic bone marrow from a donor with systemic lupus erythematosus (SLE): Successful outcome in the recipient and induction of an SLE flare in the donor. Ann Rheum Dis, 55:9, pp. 638-641.
44. Snowden, JA, Atkinson, K. Kearney, P. et al. (1997) Allogeneic bone marrow transplantation from a donor with severe active rheumatoid arthritis not resulting in adoptive transfer of disease to recipient. Bone Marrow Transplant, 20:1, pp. 71-73.
45. Marmont, AM (2004) Stem cell transplantation for autoimmune disorders. Coincidental autoimmune disease in patients transplanted for conventional indications. Best Pract Res Clin Haematol, 17:2, pp. 223-232.
46. Euler, HH, Marmont, AM Bacigalupo, A. et al. (1996) Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation. Blood, 88:9, pp. 3621-3625.
47. Rosler, W., Manger, B. Repp, R. et al. (1998) Autologous PBPCT in a patient with lymphoma and Sjogren's syndrome: Complete remission of lymphoma without control of the autoimmune disease. Bone Marrow Transplant, 22:2, pp. 211-213.
48. Ferraccioli, G., Damato, R. De Vita, S. et al. (2001) Haematopoietic stem cell transplantation (HSCT) in a patient with Sjogren's syndrome and lung malt lymphoma cured lymphoma not the autoimmune disease. Ann Rheum Dis, 60:2, pp. 174-176.
49. Shoenfeld, Y. and Isenberg, DA (1989) The mosaic of autoimmunity. Immunol Today, 10:4, pp. 123-126.
50. Fathman, CG, Soares, L., Chan, SM and Utz, PJ (2005) An array of possibilities for the study of autoimmunity. Nature, 435:7042, pp. 605-611.
51. Van Wijk, F., Roord, S. and Vastert, Bea (2008) Regulator T cells in autologous stem cell transplantation for autoimmune disease. Autoimmunity
52. Uccelli, A., Mancardi, G. and Chiesa, S. (2008) Is there a role for mesenchymal stem cells in autoimmune disease?. Autoimmunity
53. Elkon, K. (2006) Apoptosis and its relevance to autoimmunity, Karger, Basel
54. Gaipl, VS, Kuhn, A. Sheriff, A. et al. (2006) Clearance of apoptotic cells in human SLE. Apoptosis and its relevance to autoimmunity, pp. 173-187. Karger, Basel
55. Feltkamp, T. (1999) The mystery of autoimmune diseases. The decade pf autoimmunity, pp. 1-5. Elsevier, Amsterdam
56. Chiovato, L., Latrofa, F. Braverman, LE et al. (2003) Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Ann Intern Med, 139:5, pp. 346-351.
57. Goding, J. (2006) Advocatus diaboli: What is not known about autoimmune disease. The autoimmune diseases, pp. 1085-1093. Elsevier, Amsterdam
58. Lipsky, PE (2001) Systemic lupus erythematosus: An autoimmune disease of B cell hyperactivity. Nat Immunol, 2:9, pp. 764-766.
59. Liossis, S-N and Tsokos, G. (2007) B-cells in human systemic lupus erythematosus. Systemic lupus erythematosus, pp. 103-108. Mosby-Elsevier, London
60. Sherer, Y., Gorstein, A., Fritzler, MJ and Shoenfeld, Y. (2004) Autoantibody explosion in systemic lupus erythematosus: More than 100 different antibodies found in SLE patients. Semin Arthritis Rheum, 34:2, pp. 501-537.
61. Marmont, AM (1993) Immune ablation with stem-cell rescue: A possible cure for systemic lupus erythematosus? Lupus, 2:3, pp. 151-156.
62. Marmont, AM, van Lint, MT, Gualandi, F. and Bacigalupo, A. (1997) Autologous marrow stem cell transplantation for severe systemic lupus erythematosus of long duration. Lupus, 6:6, pp. 545-548.
63. Burt, RK, Traynor, A. and Ramsey-Goldman, R. (1997) Hematopoietic stem-cell transplantation for systemic lupus erythematosus. N Engl J Med, 337:24, pp. 1777-1778.
64. Joske, DJ, Ma, DT, Langlands, DR and Owen, ET (1997) Autologous bone-marrow transplantation for rheumatoid arthritis. Lancet, 350:9074, pp. 337-338. 350:9074 pp. 337-338.
65. Fassas, A., Anagnostopoulos, A. Kazis, A. et al. (1997) Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: First results of a pilot study. Bone Marrow Transplant, 20:8, pp. 631-638.
66. Fouillard, L., Gorin, NC Laporte, JP et al. (1999) Control of severe systemic lupus erythematosus after high-dose immunusuppressive therapy and transplantation of CD34+ purified autologous stem cells from peripheral blood. Lupus, 8:4, pp. 320-323.
67. Brunner, M., Greinix, HT Redlich, K. et al. (2002) Autologous blood stem cell transplantation in refractory systemic lupus erythematosus with severe pulmonary impairment: A case report. Arthritis Rheum, 46:6, pp. 1580-1584.
68. Marmont, AM, Gualandi, F. van Lint, MT et al. (2006) Long term complete remission of severe nephrotic syndrome secondary to diffuse global (IV-G) lupus nephritis following autologous, haematopoietic peripheral stem (CD34+) cell transplantation. Lupus, 15:1, pp. 44-46.
69. Tyndall, A. and Saccardi, R. (2005) Haematopoietic stem cell transplantation in the treatment of severe autoimmune disease: Results from phase I/II studies, prospective randomized trials and future directions. Clin Exp Immunol, 141:1, pp. 1-9.
70. Tyndall, A. and LeBlanc, K. (2006) Stem cells and rheumatology: Update on adult stem cell therapy in autoimmune diseases. Arthritis Rheum, 55:4, pp. 521-525.
71. Sorror, ML, Maris, MB Storb, R. et al. (2005) Hematopoietic cell transplantation (HCT)-specific comorbidity index: A new tool for risk assessment before allogeneic HCT. Blood, 106:8, pp. 2912-2919.
72. Burt, RK, Marmont, A. Oyama, Y. et al. (2006) Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: The evolution from myeloablative to lymphoablative transplant regimens. Arthritis Rheum, 54:12, pp. 3750-3760.
73. Jones, RJ, Barber, JP Vala, MS et al. (1995) Assessment of aldehyde dehydrogenase in viable cells. Blood, 85:10, pp. 2742-2746.
74. Brodsky, R. and Jones, R. (2008) Intensive immunosuppression with high dose cyclophosphamide but without stem cell rescue for severe autoimmunity: Advantages and disadvantages. Autoimmunity
75. Voltarelli, JC, Couri, CE Stracieri, AB et al. (2007) Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. Jama, 297:14, pp. 1568-1576.
76. Gratwohl, A., Passweg, J. Bocelli-Tyndall, C. et al. (2005) Autologous hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant, 35:9, pp. 869-879.
77. Muraro, PA and Douek, DC (2006) Renewing the T cell repertoire to arrest autoimmune aggression. Trends Immunol, 27:2, pp. 61-67.
78. Sun, W., Popat, U. Hutton, G. et al. (2004) Characteristics of T-cell receptor repertoire and myelin-reactive T cells reconstituted from autologous haematopoietic stem-cell grafts in multiple sclerosis. Brain, 127, pp. 996-1008.
79. Brenner, MK (2004) Haematopoietic stem cell transplantation for autoimmune disease: Limits and future potential. Best Pract Res Clin Haematol, 17:2, pp. 359-374.
80. Muraro, PA, Douek, DC Packer, A. et al. (2005) Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. J Exp Med, 201:5, pp. 805-816.
81. Abrahamsson, S. and Muraro, P. (2008) Immune re-education following autologous hematopoietic stem cell transplantation for autoimmune diseases. Autoimmunity
82. De Kleer, I., Vastert, B. Klein, M. et al. (2006) Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network. Blood, 107:4, pp. 1696-1702.
83. Burt, RK, Slavin, S., Burns, WH and Marmont, AM (2002) Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: Getting closer to a cure?. Blood, 99:3, pp. 768-784.
84. Brinkman, DM, Jol-van der Zijde, CM ten Dam, MM et al. (2007) Resetting the adaptive immune system after autologous stem cell transplantation: Lessons from responses to vaccines. J Clin Immunol, 27:6, pp. 647-658.
85. Illei, GG (2006) Hematopoietic stem cell transplantation in autoimmune diseases: Is the glass half full or half empty?. Arthritis Rheum, 54:12, pp. 3730-3734.
86. Editorial (1977) Aplastic anemia: Seed or soil. Lancet, 8041, pp. 748-750.
87. Marmont, AM (1983) The autoimmune myelopathies. Acta Haematol, 69:2, pp. 73-97.
88. Young, NS, Calado, RT and Scheinberg, P. (2006) Current concepts in the pathophysiology and treatment of aplastic anemia. Blood, 108:8, pp. 2509-2519.
89. Bacigalupo, A. (2007) Aplastic anemia: Pathogenesis and treatment. Hematology Am Soc Hematol Educ Program, 2007, pp. 23-28.
90. Griffith, LM, Pavletic, SZ Tyndall, A. et al. (2005) Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease: Position statement from a national institute of allergy and infectious diseases and national cancer institute-sponsored international workshop, bethesda, MD, march march 12 and 13, 2005. Biol Blood Marrow Transplant, 11:11, pp. 862-870.
91. Appelbaum, FR (2001) Haematopoietic cell transplantation as immunotherapy. Nature, 411:6835, pp. 385-389.
92. Marmont, AM (2004) Is there any evidence of a graft-versus-autoimmunity effect in allogeneic transplantation?. Blood Marrow Transplant, p. 11.
93. Hinterberger, W., Hinterberger-Fischer, M. and Marmont, A. (2002) Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcome after stem cell transplantation in human autoimmune diseases. Bone Marrow Transplant, 30:11, pp. 753-759.
94. Marmont, AM (2008) Will hematopoietic stem cell transplantation cure human autoimmune diseases?. J Autoimmun, 30:3, pp. 145-150.
95. Chakrabarti, S., Handa, SK Bryon, RJ et al. (2001) Will mixed chimerism cure autoimmune diseases after a nonmyeloablative stem cell transplant?. Transplantation, 72:2, pp. 340-342.
96. Burt, RK, Oyama, Y. Verda, L. et al. (2004) Induction of remission of severe and refractory rheumatoid arthritis by allogeneic mixed chimerism. Arthritis Rheum, 50:8, pp. 2466-2470.
97. Vanikar, AV, Modi, PR Patel, RD et al. (2007) Hematopoietic stem cell transplantation in autoimmune diseases: The Ahmedabad experience. Transplant Proc, 39:3, pp. 703-708.
98. Lowenthal, RM, Francis, H. and Gill, DS (2006) Twenty-year remission of rheumatoid arthritis in 2 patients after allogeneic bone marrow transplant. J Rheumatol, 33:4, pp. 812-813.
99. McKendry, RJ, Huebsch, L. and Leclair, B. (1996) Progression of rheumatoid arthritis following bone marrow transplantation. A case report with a 13-year followup. Arthritis Rheum, 39:7, pp. 1246-1253.
100. Tapprich, C., Fenk, R. Schneider, P. et al. (2003) Early recurrence of rheumatoid arthritis after nonmyeloablative allogeneic blood stem cell transplantation in a patient with multiple myeloma. Bone Marrow Transplant, 32:6, pp. 629-631.
101. Marmont, AM, Gualandi, F., Van Lint, MT and Bacigalupo, A. (2003) Refractory Evans' syndrome treated with allogeneic SCT followed by DLI. Demonstration of a graft-versus-autoimmunity effect. Bone Marrow Transplant, 31:5, pp. 399-402.
102. Marmont, AM, Gualandi, F. Occhini, D. et al. (2006) Catastrophic relapse of Evans syndrome five years after allogeneic BMT notwithstanding full donor chimerism. Terminal hemolytic-uremic syndrome. Autoimmunity, 39:6, pp. 505-511.
103. Hoyer, BF, Manz, RA, Radbruch, A. and Hiepe, F. (2005) Long-lived plasma cells and their contribution to autoimmunity. Ann N Y Acad Sci, 1050, pp. 124-133.
104. Flynn, CM and Kaufman, DS (2007) Donor cell leukemia: Insight into cancer stem cells and the stem cell niche. Blood, 109:7, pp. 2688-2692.
105. McCann, S. and Wright, E. (2003) Donor leukaemia: Perhaps a more common occurrence than we thought!. Bone Marrow Transplant, 32:5, pp. 455-457.
106. Hertenstein, B., Hambach, L. Bacigalupo, A. et al. (2005) Development of leukemia in donor cells after allogeneic stem cell transplantation-a survey of the European Group for Blood and Marrow Transplantation (EBMT). Haematologica, 90:7, pp. 969-975.
107. Marmont, AM (2006) Allogeneic haematopoietic stem cell transplantation for severe autoimmune diseases: Great expectations but controversial evidence. Bone Marrow Transplant, 38:1, pp. 1-4.
108. Tyndall, A. (2006) Allogeneic bone marrow transplantation for autoimmune disease-the jury is still out. J Rheumatol, 33:4, pp. 644-646.
109. Hinterberger, W., Rowlings, PA Hinterberger-Fischer, M. et al. (1997) Results of transplanting bone marrow from genetically identical twins into patients with aplastic anemia. Ann Intern Med, 126:2, pp. 116-122.
110. Block, SR (2006) A brief history of twins. Lupus, 15:2, pp. 61-64.
111. McColl, GJ, Szer, J. and Wicks, IP (2005) Sustained remission, possibly cure, of seronegative arthritis after high-dose chemotherapy and syngeneic hematopoietic stem cell transplantation. Arthritis Rheum, 52:10, p. 3322.
112. van Oosterhout, M., Verburg, RJ Levarht, EW et al. (2005) High dose chemotherapy and syngeneic stem cell transplantation in a patient with refractory rheumatoid arthritis: Poor response associated with persistence of host autoantibodies and synovial abnormalities. Ann Rheum Dis, 64:12, pp. 1783-1785.
113. Siatskas, C., Chan, J. Field, J. et al. (2006) Gene therapy strategies towards immune tolerance to treat the autoimmune diseases. Curr Gene Ther, 6:1, pp. 45-58.
114. Alderuccio, F., Chan, J. and Toh, B-H (2008) Tweaking the immune system Gene therapy-assisted autologous haemopoietic stem cell transplantation as a treatment for autoimmune disease. Autoimmunity